GlassScriptPhysician profile
Michael Massari
NPI 1790309011
$2,428.38
in general payments reported to CMS, 2019-2025
9 companies · $658 in 2025
The $658 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,350 · 2024: $420 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,146.58 | 2023-2025 | Rezum Generator, Lithovue, Ams 700 |
| Coloplast Corp | $609.31 | 2023-2025 | Titan |
| Endo Pharmaceuticals INC. | $269.67 | 2023 | Xiaflex |
| Valencia Technologies Corporation | $155.18 | 2025 | Ecoin Device Kit |
| Astellas Pharma US INC | $112.35 | 2023 | Xtandi |
| Antares Pharma, INC. | $50.00 | 2023 | Xyosted, Tlando |
| Tolmar, INC. | $33.40 | 2025 | Eligard |
| Sumitomo Pharma America, INC. | $27.82 | 2025 | Gemtesa |
| Urogen Pharma, INC. | $24.07 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Massari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.